Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2013 | 12-2012 | 09-2012 | 08-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -243 | -1,160 | -995 | N/A | -796 |
| Depreciation Amortization | 38 | 151 | 104 | N/A | 55 |
| Accounts payable and accrued liabilities | 2 | 2 | 8 | N/A | 16 |
| Other Working Capital | 68 | 152 | 87 | N/A | 51 |
| Other Operating Activity | 85 | 505 | 490 | 0 | 425 |
| Operating Cash Flow | $-49 | $-350 | $-305 | $N/A | $-249 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -15 | -15 | N/A | -15 |
| Other Investing Activity | 0 | -198 | -198 | 0 | -198 |
| Investing Cash Flow | $N/A | $-213 | $-213 | $N/A | $-213 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 33 | 188 | 160 | N/A | 93 |
| Common Stock Issued | 35 | 373 | 373 | N/A | 373 |
| Other Financing Activity | 0 | -4 | -4 | 0 | -4 |
| Financing Cash Flow | $68 | $557 | $530 | $N/A | $462 |
| Beginning Cash Position | 6 | 12 | 12 | N/A | 12 |
| End Cash Position | 25 | 6 | 24 | N/A | 12 |
| Net Cash Flow | $18 | $-5 | $12 | $N/A | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49 | -350 | -305 | N/A | -249 |
| Capital Expenditure | N/A | -15 | -15 | N/A | -15 |
| Free Cash Flow | -49 | -365 | -320 | 0 | -264 |